Por favor, use este identificador para citar o enlazar este ítem: 
        https://hdl.handle.net/11000/30957
    
    
    
    
Multivalent Choline Dendrimers Increase Phagocytosis of Streptococcus
pneumoniae R6 by Microglial Cells
 
| Título : Multivalent Choline Dendrimers Increase Phagocytosis of Streptococcus
pneumoniae R6 by Microglial Cells
 | 
| Autor : Ribes, Sandra
  Riegelmann, Jörn
 Redlich, Sandra
 Maestro García-Donas, Beatriz
 de Waal, Bas
  Meijer, E.W.
  Sanz, Jesús M.
 Nau, Roland
 | 
| Editor : S. Karger AG, Basel
 | 
| Fecha de publicación: 2013
 | 
| URI : https://hdl.handle.net/11000/30957
 | 
| Resumen : Background: Pneumococcal virulence factors common to all serotypes, such as choline-binding proteins (CBPs), are promising therapeutic targets in pneumococcal infections.
We studied the effect of a choline dendrimer with maximized binding affinity/specificity for CBPs on microglia-mediated pneumococcal phagocytosis. Methods: Pneumoccocal
cultures were exposed to dendrimers containing 8 choline end groups or amino groups as controls, either from the beginning of bacterial growth or at the late exponential
phase. The effect of long/short co-incubation was assessed in terms of bacterial morphological changes and increase in bacterial uptake by primary microglial cultures. Results: Inhibiting CBPs by micromolar concentrations of a choline dendrimer caused the formation of long pneumococcal chains that were readily phagocytosed by microglia. Enhanced phagocytosis was dendrimer dose-dependent. Long bacteria-dendrimer co-incubation (14 h) resulted in a higher bacterial uptake than short co-incubation (2 h; p < 0.001). Conclusions: Multivalent dendrimers containing choline end groups are promising antimicrobial agents for the management of pneumococcal diseases.
 | 
| Palabras clave/Materias: Choline-binding proteins
 Streptococcus pneumoniae
 Dendrimer
 Phagocytosis
 Microglia
 | 
| Tipo de documento : info:eu-repo/semantics/article
 | 
| Derechos de acceso: info:eu-repo/semantics/openAccess
 | 
| DOI : https://doi.org/10.1159/000353439
 | 
| Publicado en: Chemotherapy . 2013;59(2):138-42.
 | 
| Aparece en las colecciones: Instituto de Bioingeniería
 
 | 
 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
         La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.
        La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.